Sabra Health Care Reit Inc SEC Filings

Sabra Health Care REIT (SBRA) furnished materials reporting results for the three months ended September 30, 2025. The company provided a press release (Ex. 99.1), a supplemental information package (Ex. 99.2), non-GAAP reconciliations (Ex. 99.3), and an investor presentation (Ex. 99.4). These Items 2.02 and 7.01 materials are furnished, not filed, and the reconciliations and supplemental data are also available on Sabra’s investor website.

Jeffrey A. Malehorn, a director of Sabra Health Care REIT, Inc. (SBRA), was credited with 813 common stock units as dividend equivalents on 08/29/2025. These units were granted under the issuer's 2009 Performance Incentive Plan and carry a $0 per-unit acquisition price because they reflect dividend equivalent payments on previously granted stock units. After the transaction the reporting person beneficially owned 105,630 shares or share-equivalents in total, including 6,922 unvested stock units and 45,688 vested units for which payment has been deferred. Each stock unit corresponds to the right to one share and the credited units will vest and pay out on the same schedule as the original awards.

Kono Ann, a director of Sabra Health Care REIT, Inc. (SBRA), received 887 stock units on 08/29/2025 as dividend equivalent payments tied to previously granted performance-based stock units under the 2009 Performance Incentive Plan. These units were credited at no cash cost to the reporting person and will vest and be payable on the same terms as the original awards. After the transaction the reporting person beneficially owned 57,396 stock units, comprising 6,922 unvested units and 50,474 vested units for which payment has been deferred.

Reporting person: Lynne S. Katzmann, a director of Sabra Health Care REIT, Inc. (SBRA). Transaction date: 08/29/2025; Form filed: Form 4 signed 09/03/2025 by attorney-in-fact.

The report shows 813 stock units were acquired as dividend equivalent payments on previously granted stock units under the Issuer's 2009 Performance Incentive Plan at a reported price of $0. After the transaction the reporting person beneficially owns 75,405 shares equivalent, which include 6,922 unvested stock units and 45,688 vested stock units with deferred payment. Each stock unit represents the right to receive one share of the Issuer's common stock. The acquired dividend-equivalent units will vest and be payable on the same terms as the original awards.

Sabra Health Care REIT director Michael J. Foster was credited with 813 stock units on 08/29/2025 as dividend-equivalent payments tied to previously granted performance stock units; those units carry the same vesting and payment terms as the original awards. After the reported transaction, Foster beneficially owns 73,130 shares (including 6,922 unvested units and 45,688 vested units with deferred payment). In addition, Foster holds 42,411.745 shares indirectly through a 401(k) plan.

The Form 4 reflects routine insider equity compensation mechanics rather than an open-market purchase or sale: the 813 units were credited at $0 as dividend equivalents and will vest/pay under the existing plan terms.

Catherine Cusack, a director of Sabra Health Care REIT, Inc. (SBRA), was credited with 877 additional common stock units on 08/29/2025 as dividend equivalent payments under the Issuer's 2009 Performance Incentive Plan at no cash cost. Following the transaction she beneficially owns 71,276 shares or stock units in total, which includes 6,922 unvested stock units and 49,854 vested units with deferred payment. Each stock unit equals the right to receive one share of common stock and the dividend-equivalent units will vest and pay out on the same schedule as the original awards.

Sabra Health Care REIT director Craig A. Barbarosh received 813 stock units on 08/29/2025 as dividend-equivalent payments tied to previously granted performance stock units under the company's 2009 Performance Incentive Plan. After the credited units, Mr. Barbarosh beneficially owns 52,610 shares directly (including 6,922 unvested units and 45,688 vested units with deferred payment) and 94,916 shares indirectly through The Barbarosh Family Trust. The credited dividend-equivalent units will vest and pay out on the same schedule as the original awards.

Sabra Health Care REIT insider filing: Jessica Flores, Executive VP & CAO, received 367 dividend-equivalent stock units on 08/29/2025 at no cash price; these units mirror dividend payments on previously granted stock units and will vest and be payable on the same terms as the original awards. After the reported transaction, Flores beneficially owns 73,286 shares/units, which include 23,709 stock units that will be settled one-for-one into shares upon settlement. The Form 4 was signed by an attorney-in-fact on 09/03/2025. No derivative securities are reported in this filing.

Talya Nevo-Hacohen, Executive VP, CIO & Treasurer of Sabra Health Care REIT, Inc. (SBRA), reported an acquisition on 08/29/2025 of 4,390 shares of Common Stock credited as stock units representing dividend equivalents on previously granted stock units under the 2009 Performance Incentive Plan. The report shows 335,989 shares beneficially owned directly following the transaction and 529,206 shares indirectly owned through The Talya Nevo-Hacohen Trust. Of the direct holdings, 283,959 are stock units payable one-for-one in common shares upon settlement and vesting under the original awards. The Form 4 was signed by an attorney-in-fact on 09/03/2025.